Stanford University
Showing 6,601-6,620 of 36,193 Results
-
Meysam Dadgar
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioMeysam Dadgar is a Postdoctoral Research Fellow at the Molecular Imaging Program at Stanford University, School of Medicine. He obtained his Ph.D. in Biophysics from Jagiellonian University in Kraków, Poland, as part of the J-PET collaboration, and previously held a Postdoctoral Fellowship at Ghent University, Belgium.
Dr. Dadgar’s research focuses on the development and optimization of next-generation positron emission tomography (PET) systems for cancer detection and precision medicine. His expertise spans PET instrumentation, Monte Carlo and GATE simulations, advanced image reconstruction, and AI-based image enhancement. He has made significant contributions to the design and evaluation of novel PET geometries, including dual-panel and total-body PET, as well as positronium imaging approaches that extend beyond conventional PET capabilities.
In addition to his PET-focused research, Dr. Dadgar gained unique experience at CERN, where he worked on advanced detector development, including trigger electronics, PET coincidence measurements, and composite material production under controlled conditions. These experiences provided him with a strong foundation in detector design, fabrication, and calibration that complements his biomedical imaging research.
He has authored more than 20 peer-reviewed publications, including papers in Science Advances, Nature Communications, IEEE Transactions on Radiation and Plasma Medical Sciences, and EJNMMI Physics. He has been recognized with multiple international fellowships and awards, including IEEE NSS/MIC Trainee Grants and national research grants in Europe.
At Stanford, Dr. Dadgar’s work integrates state-of-the-art medical imaging technologies, particle physics methods, and AI-driven modeling to improve sensitivity, resolution, and diagnostic accuracy in PET, with the ultimate goal of advancing early cancer detection and patient care. -
Saurabh Dahiya, MD, FACP
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Saurabh Dahiya is a cancer specialist board-certified in internal medicine, hematology, and medical oncology. He serves as Associate Professor of Medicine at Stanford University School of Medicine and Clinical Director of Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy, where he provides patient-centered care for individuals with cancer.
Dr. Dahiya’s research focuses on advancing cellular immunotherapies for hematologic malignancies, including CAR T-cell platforms and next-generation multiantigen targeting strategies for lymphoma. His work aims to address high tumor bulk disease and develop novel cell therapy approaches that enhance durability and response in hematologic cancers. He leads multiple investigator-initiated and industry-sponsored trials in cellular immunotherapy with a focus on translating correlative research insights into improved patient outcomes.
He has authored more than 100 peer-reviewed publications in journals such as The New England Journal of Medicine, Nature Medicine, Journal of Clinical Oncology, Blood, and Blood Advances. Dr. Dahiya serves as Hematology Lead Editor for Critical Reviews in Oncology and Hematology and is an active member of ASH, ASTCT, and ASCO. Before joining Stanford, he was on faculty at the University of Maryland’s Greenebaum Comprehensive Cancer Center, where he helped develop the Cellular Immunotherapy Program. -
Gary Dahl
Professor of Pediatrics (Hematology/Oncology), Emeritus
Current Research and Scholarly InterestsHematology/Oncology, Phase I drug studies for childhood cancer, overcoming multidrug resistance in leukemia and solid tumors, biology and treatment of acute nonlymphocytic leukemia, early detection of central nervous system leukemia by measuring growth, factor binding proteins.
